CATAPLEXY NARCOLEPSY

Clinical trials for CATAPLEXY NARCOLEPSY explained in plain language.

Never miss a new study

Get alerted when new CATAPLEXY NARCOLEPSY trials appear

Sign up with your email to follow new studies for CATAPLEXY NARCOLEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug shows promise for Narcolepsy's worst symptoms

Symptom relief Completed

This Phase 2 trial tested AXS-12 (reboxetine) in 21 adults with narcolepsy and cataplexy. Participants received either the drug or a placebo for three weeks, then switched. The goal was to see if AXS-12 could reduce weekly cataplexy attacks and improve excessive daytime sleepines…

Matched conditions: CATAPLEXY NARCOLEPSY

Phase: PHASE2 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 14:00 UTC

CATAPLEXY NARCOLEPSY

Get alerted when new CATAPLEXY NARCOLEPSY trials appear

New drug shows promise for Narcolepsy's worst symptoms